For the first quarter 2019: ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported its financial results for the three months ended March 31, 2019 and reaffirmed its 2019 financial guidance.
Though ANI Pharmaceuticals’s net revenue grew $5 million in 2019, the company logged a nearly $24 million increase in spending. According to ANI’s annual report released Thursday, the company logged ...
For the full year ended December 31, 2018: For the fourth quarter 2018: Guidance for 2019: ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported its financial results for the three and ...
BAUDETTE, Minn., June 12, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present on June 18, 2019 at Raymond James' Life Sciences and MedTech Conference in New York City. Arthur ...